Where research becomes treatment in real time

Ovarian cancer has now less secrets

A research conducted in EIO, funded by AIRC, reveals for the first time all the proteins involved in the disease. The possibility of new effective drugs is now much closer

• For more information

Breast cancer, a new mechanism of drug resistance has been unraveled

Identified the genetic alteration underlying drug resistance in the most common type of breast tumor

• For more information

Discovery of a new genetic neurodevelopmental disease

A research carried out at the European Institute of Oncology identifies the mechanism responsible for a severe neurodevelopment syndrome

• For more information

Hunting genes responsible for hereditary diseases

A revolutionizing test mapping the risk of cancer incidence

• For more information

HPV virus and cancer: an even tighter link than previously known

A study in EIO, funded by AIRC, unravels the mechanism responsible for the cause-effect relationship between HPV virus and several tumor types

• For more information

Umberto Veronesi Memorial Award 2017

The first prize in memory of Umberto Veronesi awarded to Dr. Giuseppe Curigliano, Director of the IEO Division of New Drugs and Early Drug Development for Innovative Therapies.

• For more information

15 March 2017

HITTING BREAST CANCER AT ITS ORIGIN: THE STEM CELLS

Cancer research is getting closer in overcoming chemoresistance in more aggressive tumors

• For more information

30 January 2017

OVARIAN TUMOR, GENETICS OPENS NEW FRONTIERS

At IEO the best surgeons in the world discuss the newly opened frontiers in ovarian cancer treatments

• For more information

29 July 2016

Cardiotoxicity at IEO: a new study reveals its importance

• For more information

03 June 2016

IEO RESULTS AT THE 2016 ASCO ANNUAL MEETING

The latest results from immunotherapy studies involving IEO were at the center of our participation in the 2016 ASCO Annual Meeting in Chicago from the 3rd to the 7th of June.

• For more information